Topical Rapamycin — Vitiligo’s Next Big Hope? (Ep. 54)
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Topical Rapamycin — Vitiligo’s Next Big Hope? (Ep. 54)
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
From Easter Island soil to modern skin science — meet rapamycin, the molecule that might just change vitiligo care.
Once known mainly as an anti-rejection drug for organ transplants, rapamycin is now being tested as a topical treatment that could both calm the immune attack and help pigment return. Early studies look promising: minimal side effects, slow but steady repigmentation, and surprisingly good tolerance.
In this episode, we explore:
- How rapamycin rewires the skin’s immune balance
- Why it’s called both a suppressor and a rejuvenator
- What Phase II trials are revealing so far
- And whether this “longevity drug” might also restore color to the skin
It’s too early to call it a breakthrough — but this little molecule from a far-off island might just be the next quiet revolution in vitiligo therapy.
Full story: Topical Rapamycin: Could This Be Vitiligo’s Next Big Breakthrough?
Pas encore de commentaire